Assuming the remaining Phase 3 data continues to support both safety and efficacy, and the FDA review process moves forward without delays, industry projections currently point to a possible late 2026 to 2027 timeline
Grifols did not provide data on how many adverse reactions have followed donations in Canada
To prevent any potential issues, always use a new needle, clean the skin properly before injecting, rotate injection sites regularly, and never inject into areas that are bruised, scarred, or irritated
Call our trusted team on 0117 369 6476 to book a free consultation and find out more about the treatments we provide
The SUSTAIN 15 and 7 trials compared semaglutide to either placebo or other existing hypoglycemic agents
It reduces inflammation and oxidative damage at wound sites, creating an optimal environment for recovery